ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637130 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637130; 2) Community: the network communities that were significantly associated with the response to NSC 637130; 3) Molecule: the relationships between components within communities and NSC 637130; 4) MDR: the compounds that were significantly associated with the NSC 637130.

NSC Compound Enrichment Correlation
NSC 129757 Null 0.0385613993886001 0.067080321
NSC 13973 Acridine yellow 0.0385613993886001 0.55228132
NSC 144126 Null 0.0385613993886001 -0.1145413
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0385613993886001 0.46415757
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0385613993886001 0.43118043
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0385613993886001 0.46044021
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0385613993886001 0.46411695
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0385613993886001 0.11819953
NSC 339137 PHYSALOLACTONE 0.0385613993886001 0.23829943
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0385613993886001 0.46415902
Total:103  Current:71    [First] [Prev] [Next] [Last]